Qingqing Sang
Overview
Explore the profile of Qingqing Sang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu J, Chen M, Sang Q, Li F, Xu Z, Yu B, et al.
Adv Sci (Weinh)
. 2024 Dec;
12(7):e2409050.
PMID: 39731339
Poor response to 5-fluorouracil (5-FU) remains an obstacle in the treatment of gastric cancer (GC). Super enhancers (SEs) are crucial for determining tumor cell survival under drug pressure. SE landscapes...
2.
Fan Z, Li F, Jiang X, Pan T, Zang M, Li J, et al.
Clin Transl Med
. 2024 Oct;
14(11):e70069.
PMID: 39456121
No abstract available.
3.
Feng H, Yu J, Xu Z, Sang Q, Li F, Chen M, et al.
EBioMedicine
. 2024 Oct;
109:105375.
PMID: 39437660
Background: SLC7A9 is responsible for the exchange of dibasic amino acids and cystine (influx) for neutral amino acids (efflux). Cystine/cysteine transport is related to ferroptosis. Methods: Sanger sequencing detected TP53...
4.
Zhu N, Zhao Y, Yan W, Wei L, Sang Q, Li J, et al.
Cancer Cell Int
. 2024 May;
24(1):167.
PMID: 38734676
Background: Accumulating evidences indicate that the specific alternative splicing (AS) events are linked to the occurrence and prognosis of gastric cancer (GC). Nevertheless, the impact of AS is still unclear...
5.
Xie Y, Sang Q, Da Q, Niu G, Deng S, Feng H, et al.
Artif Intell Med
. 2024 Apr;
152:102871.
PMID: 38685169
For the diagnosis and outcome prediction of gastric cancer (GC), machine learning methods based on whole slide pathological images (WSIs) have shown promising performance and reduced the cost of manual...
6.
Li F, Yu J, Pan T, Feng H, Li J, Yu B, et al.
Adv Sci (Weinh)
. 2023 Oct;
10(34):e2303091.
PMID: 37863665
Erlotinib, an EGFR tyrosine kinase inhibitor, is used for treating patients with cancer exhibiting EGFR overexpression or mutation. However, the response rate of erlotinib is low among patients with gastric...
7.
Hou J, Pan T, Li F, Sang Q, Wu X, Li J, et al.
Biochem Pharmacol
. 2023 Oct;
217:115849.
PMID: 37806457
Cancer stem cells (CSCs) have been proposed to explain tumor relapse and chemoresistance in various types of cancers, and androgen receptor (AR) has been emerged as a potential regulator of...
8.
Yu J, Feng H, Sang Q, Li F, Chen M, Yu B, et al.
EBioMedicine
. 2023 Feb;
89:104451.
PMID: 36738481
Background: Vacuolar protein sorting-associated protein 35 (VPS35) is a core component of the retromer complex which mediates intracellular protein transport. It is well known that dysfunctional VPS35 functions in the...
9.
Sang Q, Dai W, Yu J, Chen Y, Fan Z, Liu J, et al.
Front Immunol
. 2022 Aug;
13:983632.
PMID: 36032070
Increasing evidence has elucidated that the tumor microenvironment (TME) shows a strong association with tumor progression and therapeutic outcome. We comprehensively estimated the TME infiltration patterns of 111 gastric cancer...
10.
Wang Y, Hu S, Tan X, Sang Q, Shi P, Wang C, et al.
Int J Gen Med
. 2022 Jun;
15:5247-5252.
PMID: 35651675
Purpose: The aim of this study was to screen the possible pathogenic genes of one family with tuberous sclerosis complexes (TSCs). Patients And Methods: All family members were examined through...